17 April 2014
 

A first study of cytokine genomic polymorphisms in CFS: Positive association of TNF-857 and IFNγ 874 rare alleles

Rheumatology ArticleN. Carlo-Stella, C. Badulli, A. De Silvestri, L. Bazzichi, M. Martinetti, L. Lorusso, S. Bombardieri, L. Salvaneschi, M. Cuccia

University of Pavia, Italy

CER2751
Brief Paper

Free to view (click on article PDF icon to read the article)

Abstract

OBJECTIVES:
In the past two years we have developed a biological bank of genomic DNA, cDNA, serum and red blood cells of Italian patients with certified CFS from the two Italian referral centers for the syndrome. Recent studies have shown an imbalance in cytokine production in disease states similar to Chronic Fatigue Syndrome (CFS), such as sickness behavior, both in animals and in humans. However we notice that serum cytokine concentrations are often inconstant and degrade rapidly. With this in mind, we investigated cytokine gene polymorphisms in 80 Italian patients with CFS in order to ascertain whether in this group of patients it is possible to describe a genetic predisposition to an inflammatory response.
METHODS:
We analyzed the promoter polymorphisms of IL-10, IL-6 and the IFN&ggr; 874 T/A polymorphism in intron 1 with a PCR-SSP method (Cytogen One Lambda Inc. Canoga Park, CA, U.S.A) in 54 patients and TNF-308 G/A and 857 C/T promoter polymorphisms with a PCR-RFLP method (in 54 and 80 patients respectively).
RESULTS:
There is a highly significant increase of TNF 857 TT and CT genotypes (p = 0.002) among patients with respect to controls and a significant decrease of IFN gamma low producers (A/A) (p = 0.04) among patients with respect to controls.
CONCLUSIONS:
We hypothesize that CFS patients can have a genetic predisposition to an immunomodulatory response of an inflammatory nature probably secondary to one or more environmental insults of unknown nature.

PMID: 16762155 [PubMed]

Top of the Page

Web sites for on line Journals
© Clinical and Experimental Rheumatology (Journal with On line Submission) ISSN n 1593-098X
- VAT IT-00783170509